NUKLEINSÄURE- UND GENSYNTHESE

European patent · EP4536855 · In force

Register entry

Publication number
EP4536855
Application number
EP23733040
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 8, 2023
Published
Apr 16, 2025
Granted
Dec 31, 2025
Protection ends at the latest
Jun 7, 2043
Next annual fee due
Jun 30, 2027
IPC classes
C12Q 1/6806 (2018.01)
C12N 15/10 (2006.01)
C12N 15/00 (2006.01)
Priority
GB 202208495 10.06.2022
PCT application
PCT/GB2023/051497 08.06.2023
PCT publication
WO2023/237889 14.12.2023
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Feb 20, 2026

    Agent entered

    Representative
    BOVARD AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 20.02.2026

  3. Dec 31, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 31.12.2025

Parties

Holder

NunaBio Limited

c/o Muckle LLP Times Central 32 Gallowgate, Newcastle upon Tyne NE1 4BF, GB

Agent

Bovard AG

BOVARD AG

Optingenstrasse 16, 3013 Bern

Inventor

PIKE, Andrew Robert

Newcastle upon Tyne Tyne and Wear NE3 2HR, GB

TUITE, Eimer Mary

Newcastle upon Tyne Tyne and Wear NE7 7RZ, GB

HEDLEY, Joseph Henry

Longframlington Morpeth Northumberland NE65 8BQ, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.